| -0.045 / -1.83%|
The 8 analysts offering 12-month price forecasts for Solazyme Inc have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 2.00. The median estimate represents a +148.45% increase from the last price of 2.42.
The current consensus among 9 polled investment analysts is to Hold stock in Solazyme Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.